Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GenMark Diagnostics Inc (NASDAQ:GNMK)

13.14
Delayed Data
As of May 26
 +0.14 / +1.08%
Today’s Change
7.05
Today|||52-Week Range
13.67
+7.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$618.7M

Company Description

GenMark Diagnostics, Inc. is a molecular diagnostics company. The firm focuses on the development and commercializing of its its proprietary eSensor detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Contact Information

GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad California 92008-8829
P:(760) 448-4300
Investor Relations:

Employees

Shareholders

Individual stakeholders9.34%
Mutual fund holders55.21%
Other institutional47.45%

Top Executives

Hany MassaranyPresident, Chief Executive Officer & Director
Scott MendelCFO & Principal Accounting Office
Jon Faiz KayyemSenior Vice President-Research & Development
Eric J. StierSecretary, Senior Vice President & General Counsel
Michael GleesonSenior VP-North American Commercial Operations